Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen

Expertise Across Various Cell Types

Our comprehensive cell therapy portfolio spans a wide range of cell types including CAR-T, TCR, TILs, and more

€90M+ Invested in European Capabilities

Integrated development, manufacturing and packaging of biologics and sterile injectables

Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen

Expertise Across Various Cell Types

Our comprehensive cell therapy portfolio spans a wide range of cell types including CAR-T, TCR, TILs, more

€90M+ Invested in European Capabilities

Integrated development, manufacturing and packaging of biologics and sterile injectables